| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Smith Barry M, Director
Gave 5,100 shares as a gift ($187K) |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Conference Call and Webcast scheduled for tomorrow, November 5, 2026 at 10:00 am MT |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 27 Oct 2026 |
Form 4: Gochnour John J, Chief Operating Officer
Received 5,948 shares by exercise or conversion ($36.3K) · Gave up 6,624 shares to cover exercise price or tax ($279K) |
| 19 Oct 2026 |
Form 4: Covey Stephen M R, Director
Received 1,900 shares as a grant or award |
| 19 Oct 2026 |
Form 4: Morris Gregory K Sr., Director
Received 1,900 shares as a grant or award |
| 19 Oct 2026 |
Form 4: Snapper Suzanne D., Director
Received 1,900 shares as a grant or award |
| 19 Oct 2026 |
Form 4: Smith Barry M, Director
Received 1,900 shares as a grant or award |
| 19 Oct 2026 |
Form 4: Lamb Scott E, Director
Received 2,400 shares as a grant or award |
| 19 Oct 2026 |
Form 4: Nackel John G., Director
Received 1,900 shares as a grant or award |
| 19 Oct 2026 |
Form 4: Christensen Christopher R., Director
Received 1,900 shares as a grant or award |
| 10 Aug 2026 |
Form 4: Cheney Kirk Sterling, EVP, GC and Corp Secy
Sold 1,393 shares ($53.7K) |
| 10 Aug 2026 |
Form 4: Guerisoli Brent, Chief Executive Officer
Sold 4,285 shares ($165K) |
| 10 Aug 2026 |
Form 4: Steik Jason Paul, Chief Clinical Officer
Sold 1,394 shares ($53.7K) |
| 06 Aug 2026 | 144 |
| 06 Aug 2026 | 144 |
| 06 Aug 2026 | 144 |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Conference Call and Webcast scheduled for tomorrow, August 6, 2026 at 10:00 am MT |
Loading...